Implementation Considerations for ATTR-CM Screening

This guide outlines the implementation considerations for screening patients for transthyretin amyloid cardiomyopathy (ATTR-CM). It emphasizes the importance of early detection for effective disease management, noting the challenges posed by the complexity of clinical criteria and the multi-system impact of ATTR-CM. The document details a structured approach to integrate simplified clinical criteria into existing care workflows, aiming to enhance screening efficiency without overburdening healthcare systems. Key steps include identifying gaps in current detection methods, selecting appropriate simplified criteria based on patient population nuances, and ensuring effective communication and education for healthcare providers. The guide also discusses the need for thoughtful patient referral processes and the importance of involving various healthcare professionals in the implementation strategy to foster buy-in and streamline workflows. Overall, the document serves as a resource for hospitals and health systems to improve early detection and management of ATTR-CM.